VIEMED HEALTHCARE, INC.·4

Feb 2, 5:35 PM ET

Fitzgerald Trae 4

Research Summary

AI-generated summary

Updated

Viemed Healthcare (VMD) CFO Trae Fitzgerald Receives and Sells Shares

What Happened
Trae Fitzgerald, Chief Financial Officer of Viemed Healthcare (VMD), reported vesting and settlement of equity awards on January 29, 2026. The filing shows conversion/exercise of derivative awards (RSUs and phantom share units) leading to the acquisition of 9,794 and 3,265 underlying shares, followed by company actions to satisfy tax and cash-settlement requirements: 2,679 shares were withheld to cover taxes (disposed at $7.48/share for $20,039) and 3,265 shares were disposed to the issuer at $7.48/share for $24,422. The filing also records derivative settlements reported at $0 value reflecting cash settlement of phantom shares.

Key Details

  • Transaction date: January 29, 2026. Form filed: February 2, 2026 (appears timely).
  • Reported transactions:
    • Conversion/exercise of derivatives (M): 9,794 shares acquired (reported as derivative settlement).
    • Conversion/exercise of derivatives (M): 3,265 shares acquired.
    • Tax withholding (F): 2,679 shares withheld/disposed at $7.48 each = $20,039.
    • Disposition to issuer (D): 3,265 shares sold to company at $7.48 each = $24,422.
    • Derivative dispositions (M) for 9,794 and 3,265 shares reported at $0 reflecting cash settlement.
  • Footnotes of note:
    • F1/F5: RSUs represent rights to one common share; the RSUs were originally granted Jan 29, 2024 and vest in three annual installments.
    • F4/F6: Phantom share units are cash-settled equivalents of common shares; settlement was cash-based and reported as simultaneous acquisition of underlying shares and disposition to the company.
    • F2: Shares were withheld by the issuer to satisfy the reporting person’s tax obligation.
  • Shares owned after the transactions are not specified in this Form 4.

Context: This appears to be routine vesting/settlement of RSUs and phantom share units with tax withholding and cash settlement to the company rather than an open-market sale or purchase. Such filings typically reflect compensation realization and tax-related withholding and do not, by themselves, indicate the insider’s market view.